Search
Fate Therapeutics Inc
FATEAdd to Watchlist
2.090USD
+0.130+6.63%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
241.10MMarket Cap
LossP/E TTM
Fate Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Fate Therapeutics Inc is 7.14, ranking 258 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.92, which is -76.07% below the recent high of -0.46 and -166.24% above the recent low of -5.11.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
